Source:http://linkedlifedata.com/resource/pubmed/id/10391090
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1999-7-19
|
| pubmed:abstractText |
To investigate the contribution of the beta-catenin gene to the development of ovarian carcinomas, mutational analysis of exon 3 of the beta-catenin gene was conducted. We analyzed 61 primary ovarian carcinomas, consisting of 49 non-endometrioid-type and 12 endometrioid-type tumors, for genetic alteration of the beta-catenin gene. Five carcinomas showed beta-catenin mutations (S37C, T41I, T41A), including 4 (33%) of 12 endometrioid-type tumors and 1 (14%) of 7 mucinous-type tumors. All of these mutations altered at the serine/threonine residues that are potential sites of GSK3-beta phosphorylation. We detected no carcinomas with interstitial deletion involving exon 3 of beta-catenin. Furthermore, we immunohistochemically studied 27 of the 61 ovarian carcinomas. Both nuclear and cytoplasmic beta-catenin expressions were demonstrated in 4 of the 27 ovarian carcinomas for which tissue samples were available for examination. All 4 cases exhibited mutations in exon 3 of beta-catenin, including a mucinous carcinoma. Our results suggested that beta-catenin gene mutation at potential GSK3-beta phosphorylation sites results in accumulation of beta-catenin protein within the cells and its translocation to nuclei. Accumulated beta-catenin protein may be involved in the development of endometrioid-type ovarian carcinomas, and some mucinous-type ovarian carcinomas.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
0910-5050
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
90
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
510-5
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:10391090-Adult,
pubmed-meshheading:10391090-Carcinoma, Endometrioid,
pubmed-meshheading:10391090-Cytoskeletal Proteins,
pubmed-meshheading:10391090-DNA Mutational Analysis,
pubmed-meshheading:10391090-Female,
pubmed-meshheading:10391090-Genome, Human,
pubmed-meshheading:10391090-Humans,
pubmed-meshheading:10391090-Immunohistochemistry,
pubmed-meshheading:10391090-Japan,
pubmed-meshheading:10391090-Middle Aged,
pubmed-meshheading:10391090-Ovarian Neoplasms,
pubmed-meshheading:10391090-Trans-Activators,
pubmed-meshheading:10391090-beta Catenin
|
| pubmed:year |
1999
|
| pubmed:articleTitle |
Mutational analysis of beta-catenin gene in Japanese ovarian carcinomas: frequent mutations in endometrioid carcinomas.
|
| pubmed:affiliation |
Department of Obstetrics and Gynecology, Cancer Research Institute, Sapporo Medical University School of Medicine, Hokkaido. sagaes@sapmed.ac.jp
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|